Microislet, Inc.

San Diego, CA 92129

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.85MM
First Award Date 06/01/03
Most Recent Award Date 05/01/08

Key Personnel

Last Name Name Awards Contact
Stuiver Ingrid Stuiver 5

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 05/01/08 - 04/30/10

DESCRIPTION (provided by applicant): Encapsulated porcine (xeno) islet transplantation for the treatment of Type I Diabetes (T1D) is currently considered to be the next generation product for islet transplantation. The issue of tissue shortage is easily addressed by the use of porcine islets, however the immune component that compromises graft s...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-93
Budget: 09/01/07 - 08/31/08

DESCRIPTION (provided by applicant): The concept of islet allotransplantation as a treatment for Type I Diabetes has been demonstrated as feasible by the pioneering work done in Edmonton, Miami, Minneapolis, Philadelphia and other sites during the last five years. However, there still exists a considerable shortage of tissue for transplantation....

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-93
Budget: 09/01/06 - 08/31/07

DESCRIPTION (provided by applicant): The concept of islet allotransplantation as a treatment for Type I Diabetes has been demonstrated as feasible by the pioneering work done in Edmonton, Miami, Minneapolis, Philadelphia and other sites during the last five years. However, there still exists a considerable shortage of tissue for transplantation....

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-93
Budget: 09/20/05 - 08/31/06

DESCRIPTION (provided by applicant): The concept of islet allotransplantation as a treatment for Type I Diabetes has been demonstrated as feasible by the pioneering work done in Edmonton, Miami, Minneapolis, Philadelphia and other sites during the last five years. However, there still exists a considerable shortage of tissue for transplantation....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/03 - 12/31/03

DESCRIPTION (provided by applicant): Islet allotransplatation has been demonstrated to greatly reduce or eliminate the requirement for exogenous insulin injection in patients with insulin-dependent diabetes mellitus. This experimental procedure offers diabetic patients hope for improved blood glucose regulation and, consequently, a reduced ris...